247 related articles for article (PubMed ID: 32122592)
21. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
22. Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
Li J; Yu T; Zhang F; Wang X; Zhou J; Gao X; Gao S; Liu X
Arch Virol; 2017 Jan; 162(1):235-246. PubMed ID: 27722993
[TBL] [Abstract][Full Text] [Related]
23. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.
Seo HW; Oh Y; Han K; Park C; Chae C
BMC Vet Res; 2012 Oct; 8():194. PubMed ID: 23078878
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
[TBL] [Abstract][Full Text] [Related]
25. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.
Yang K; Li W; Niu H; Yan W; Liu X; Wang Y; Cheng S; Ku X; He Q
Acta Vet Scand; 2012 Nov; 54(1):67. PubMed ID: 23171757
[TBL] [Abstract][Full Text] [Related]
28. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
[TBL] [Abstract][Full Text] [Related]
29. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
[TBL] [Abstract][Full Text] [Related]
30. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
[TBL] [Abstract][Full Text] [Related]
31. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
[TBL] [Abstract][Full Text] [Related]
32. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
Zanotti C; Martinelli N; Lelli D; Amadori M
Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
34. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
[TBL] [Abstract][Full Text] [Related]
35. A pilot comparative study of recombinant protein and whole-virus inactivated vaccines against porcine circovirus type 2 in conventionally reared pigs.
Choi JY; Lyoo KS; Kim K; Do VT; Lee KW; Hahn TW
Res Vet Sci; 2019 Apr; 123():192-194. PubMed ID: 30682582
[TBL] [Abstract][Full Text] [Related]
36. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of bivalent vaccines of porcine circovirus type 2 and
Lim J; Jin M; Yoon I; Yoo HS
J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321
[TBL] [Abstract][Full Text] [Related]
38. Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
Lee SI; Jeong CG; Ul Salam Mattoo S; Nazki S; Prasad Aganja R; Kim SC; Khatun A; Oh Y; Noh SH; Lee SM; Kim WI
Vaccine; 2021 Oct; 39(45):6691-6699. PubMed ID: 34538524
[TBL] [Abstract][Full Text] [Related]
39. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]